Skip to main content
Download PDF

The effect of T cell aging on the change of human tissue structure

Immunity & Ageing volume 21, Article number: 26 (2024) Cite this article

Abstract

The trend of aging of the global population is becoming more and more significant, and the incidence of age-related diseases continues to rise.This phenomenon makes the problem of aging gradually attracted wide attention of the society, and gradually developed into an independent research field.As a vital defense mechanism of the human body, the immune system changes significantly during the aging process.Age-induced changes in the body’s immune system are considered harmful and are commonly referred to as immune aging, which may represent the beginning of systemic aging.Immune cells, especially T cells, are the biggest influencers and participants in age-related deterioration of immune function, making older people more susceptible to different age-related diseases.More and more evidence shows that T cells play an important role in the change of human tissue structure after aging, which fundamentally affects the health and survival of the elderly.In this review, we discuss the general characteristics of age-related T cell immune alterations and the possible effects of aging T cells in various tissue structures in the human body.

Aging and T cell changes

It is well known that during the aging process, the immune system changes, that is, the disorder and decline of immune system function.In the aging state, the immune system usually shows a relatively continuous state of low activation; When stimulated by the outside world, its dynamic response becomes weaker and the amplitude is reduced, and this combination of chronic inflammatory state and reduced effective defense ability is often referred to as immune aging.

Studies have found that immune aging is associated with increased morbidity and mortality in the elderly [1]。At present, many studies have found relevant factors leading to immune senescence, which are believed to be related to Langerhans cells, dendritic (DC) cells, natural killer (NK) cells, neutrophilic granulocyte function, T cell and B cell function and lineage [2]。Although immune aging affects both the innate and acquired immune systems, the most significant is T-cell immunity [3]。Liu et al. studied various biomarkers associated with human aging in peripheral blood T cells and observed a positive relationship between chronological age and p16 expression as well as telomere shortening, confirming that T cells age with age [4]。With age, the most significant changes are the decrease of the initial T-cell (Tn) library and the increase of the Memory T cell (Tm) library, the decrease of T-cell diversity, the decrease of the number of available TCRS, and the decline of T-cell immune response function.In addition, extreme differentiation of memory T cells was observed in the elderly, and co stimulatory molecules such as CD28 and CD27 were no longer expressed, resulting in T cell aging or depletion [5].While aging and depleted T cells exhibit molecular features of aging (such as mitochondrial dysfunction and epigenetic remodeling); Second, the aging of T cells showed signs of DNA damage and short telomeres, and activate signaling pathways associated with aging [6], at the same time a series of factors, these factors are called the senescence associated secretory phenotype (SASP) [7]; With the increase of age, T cells with aging phenotype will continue to accumulate, further promoting immune aging, resulting in a decrease in immune function and an increase in pro-inflammatory function.

At present, it has been found that aging T cells may promote pathological changes in the tissue structure of various systems of the human body through a variety of mechanisms, thereby leading to related diseases and fundamentally affecting the health of the elderly.First, aging T cells continue to produce cytokines that directly promote inflammation; Secondly, aging T cells may not be able to perform the function of monitoring aging, so that they cannot clear the irreversibly damaged cells that become sensory cells, and cannot play the corresponding function in time.In addition, aging T cells can lead to the loss of autoimmune tolerance and secrete cytotoxic substances that directly damage tissues.Finally, aging T cells can also indirectly participate in various changes by regulating intestinal homeostasis.

T cells and vascular function

In recent years, with the increasing aging trend, the risk of cardiovascular disease is also increasing, which is directly related to the appearance of vascular aging [8].Vascular aging is a degenerative disease of the cardiovascular system with the increase of age, which is usually accompanied by increased stiffness of elastic arteries, decreased compliance, dysfunction of vascular endothelial cells, and weakened ability of vascular repair and regeneration [9].Vascular endothelial cell dysfunction is the early sign of vascular aging, but also the key event.Data from both in vitro and clinical studies suggest that immune system aging affects endothelial cell function and leads to age-related vascular disease [1, 10].In fact, inflammation is an important factor in endothelial cell dysfunction, chronic inflammation can lead to vascular endothelial structure and function changes.Aging of the immune system can promote chronic inflammation, which is a key mechanism of vascular endothelial injury [11].

Trott et al. demonstrated that dysfunctional T cells in older mice are involved in inducing vascular inflammation and associated vascular dysfunction [12], and that these changes may be caused by T cell senescence.Senescent T cells release SASP, including inflammatory cytokines (IL-1β, IL-6), chemokines (GRO1), protease (MMP), vascular endothelial growth factor (VEGF), NO and other signaling molecules, and hormones inducing pro-inflammatory response [13, 14], so that the body can maintain chronic inflammation.The resulting pro-inflammatory microenvironment of blood vessel wall will promote vascular dysfunction, impair cell metabolism, increase cell apoptosis, and lead to the occurrence of corresponding vascular diseases [15]; Secondly, these inflammatory cytokines promote vascular oxidative stress to a certain extent, induce the activation of matrixmetalloproteinase (MMP), degrade vascular wall collagen and elastase, and thus impair the function of vascular endothelial cells, leading to vascular wall remodeling [16]. In addition, the inflammatory factor TNF-a can regulate the damage of endothelial cells through the NF-kB signaling pathway, and TNF-a can stimulate the degradation of IkB protein in cells and activate the NF-kB signaling pathway, resulting in the transcription of genes dependent on NF-kB activation and increased binding to nuclear DNA, thus inducing apoptosis of endothelial cells and accelerating the occurrence of vascular aging [17].Importantly, selective inhibition of NF-κB in the vascular system has been shown to improve blood flow regulation, reduce systemic inflammation, exert beneficial metabolic effects and extend healthy lifespan [18].

On the other hand, studies have found that sirtuins (SIRTs) proteins play an important role in the aging process of blood vessels [19]. Sirtuin (SIRT) or Silence-information regulatory Factor 2 (Sir2) proteins are a class of proteins with nicotinamide adenine dinucleotide (NAD+) -dependent deacetylase activity or ADP-ribosyltransferase activity, which are widely distributed in cells.Currently, it has been found that SIRT1 is the most important factor involved in vascular homeostasis and disease in the SIRT family, and SIRT1 is highly expressed in endothelial cells [19].However, studies have found that SIRT1 protein levels in various aging models gradually decrease with the aging process [20].When T cells age, the expression level of SIRT1 decreases [21].However, downregulation of SIRT1 expression may lead to increased activity of proteins that inhibit cell cycle such as p53, thus inducing endothelial cell senescence [19].

In conclusion, senescent T cells, especially senescent CD8 + T cells, have reduced or depleted expression of the surface co-stimulatory molecule CD28, which is mainly clinically manifested as a significant increase in circulating CD8 + CD28-T cell subsets with aging.Studies have found that from birth to 80 years old, the proportion of CD8 + CD28-T cell subsets in the blood of healthy people increases from 0 to about 60% [22].Compared with CD28 + T cells, CD28-T cells have decreased proliferation capacity and increased expression and secretion of pro-inflammatory cytokines, and play an important role in various age-related cardiovascular diseases [23, 24].Therefore, the detection of CD8 + CD28-T lymphocytes in blood may also serve as an assessment of vascular aging and prediction of cardiovascular risk [25].

T cells and intestinal mucosal barrier

It is well known that aging is closely related to the integrity of the intestinal barrier [16].The permeability of the intestinal barrier changes with age.Experiments have confirmed that the intestinal permeability of elderly rodents to macromolecules increases, indicating that aging is also related to the deterioration of intestinal barrier function and integrity [26].Evidence shows that T lymphocytes play an important role in maintaining the integrity of the intestinal mucosal barrier [27, 28]。At the same time, immunosuppression and immune imbalance may lead to or aggravate intestinal mucosal barrier dysfunction [29].

Firstly, there are a large number of TRM cells (resident memory T cells), TReg cells (regulatory T cells) and γδT cells in the intestine [23].Gamma-delta T cells, which are most closely related to intestinal mucosal barrier function, produce regenerative factors such as keratinocyte growth factor (KGF) and IGF1 to regulate tissue homeostasis and promote epithelial cell proliferation [30, 31], epithelial integrity is also promoted through the secretion of mediators such as TGFβ1, TGFβ3, and prothymosinβ4 [32].However, it has been found in animal experiments that the proportion of γδT cells is reduced in the gut of elderly mice [33], so we believe that the decline in the number of γδT cells during aging is also an important part of the damage of intestinal mucosal barrier.

Secondly, aging T cells may lead to increased inflammatory response, and a large number of inflammatory factors may lead to dysfunction or excessive apoptosis of intestinal mucosal epithelial cells and impair intestinal mucosal barrier function [34]; In addition, a large number of inflammatory mediators will activate NF-KB (nuclear transcription factor). When NF-KB in intestinal immune cells is activated, downstream signaling molecules will be activated to promote the expression of inflammatory factors, and intestinal immune cells will be activated to cause damage to their mucosal barrier [35].

On the other hand, with the aging of T cells, the immune tolerance of T cells is decreased and the immune regulatory function is impaired, and the ability to recognize beneficial microorganisms in the intestine and immune monitoring and related regulation of harmful microorganisms is decreased, so that the intestinal mucosal barrier is out of balance.Dysfunctional gut microbiota has also been linked to unhealthy aging and age-related chronic inflammatory diseases [36]. Studies have confirmed that T cells promote local IgA responses in germinal centers, thus ensuring tolerance to symbiotic microorganisms [37], but germinal center reactions require a balance of TH17 cells and Treg cells [38, 39]. Their future also will be divided into Tfh cells and T follicular regulatory cells. Recently, iNKT cells have also been shown to control IgA by regulating intestinal flora, as well as regulating the function of intestinal Treg cells [40]. However, dysfunctional germinal center Tfh cell and excessive T follicular regulatory cell activity observed in older mice may affect gut microbiota remodeling during aging [41, 42]. Meanwhile, recent studies have shown that germinal center defects and antigen-specific IgA defects are prone to occur in the elderly [43]. These findings suggest that T cells contribute to the maintenance of a healthy and balanced gut microbiome, and that dysregulation of the gut microbiome can result from T cell aging. In addition, when intestinal flora disorders occur in the body, harmful bacteria increase in the intestine, resulting in dysfunction of intestinal mucosal barrier function and increased permeability, thus activating effector T cells, destroying the balance between them and immunosuppressive regulatory T cells, and further leading to immune function impairment [44]. In short, this loss of host-microbiome symbiosis will aggravate the destruction of the intestinal barrier, promote the spread of intestinal bacterial products throughout the body, cause inflammation, and generate pathological feedback loops that amplify this inflammatory response [45, 46].

In conclusion, T cell aging may affect the immune function, inflammatory state, immune regulation and repair ability of intestinal mucosal barrier, and thus affect the entire intestinal health state.In the elderly population, the continuous decline of intestinal mucosal immune barrier function weakens the intestinal tolerance to its own flora, external infection, malnutrition, dehydration and other conditions, thus providing favorable conditions for the invasion of gastrointestinal pathogens.Therefore, given the role of T cells in regulating intestinal stem cell(ISC) fate and intestinal integrity [47], coupled with their ability to control the gut microbiome, microbiota-T cell interactions have emerged as a potential regulator of health in older adults.Therefore, it is necessary to further study whether the function of aging T cells can be improved by regulating the intestinal microbiota (intestinal microbiota transplantation, oral probiotics, etc.), so as to curb its adverse effects.

T cells and skeletal muscle

Closely related to age - sarcopenia. It has been reported that immune aging stimulates muscle loss during aging, which can be regarded as a key factor leading to sarcopenia [48]. And T cells play an important role in the middle.

Experiments with T cell-deficient mice and activated spleen T cell mice have shown that the adaptive immune response of T cells to release cytokines to damaged muscles promotes the continuous proliferation of skeletal muscle stem cells, and aging may alter the function of T cell-induced muscle precursor cells (MPC), leading to the occurrence of sarcopenia [49]. Immune aging causes a decrease in the number of muscle stem cells (satellite cells) and transfers muscle stem cells to the fibrogenic phenotype [50], which disrupts muscle regeneration and leads to muscle atrophy. One of the findings suggests that age-related sarcopenia is directly related to muscle stem cell (MuSC) dysfunction, and that high expression of the cell surface marker CD47 (a member of the immunoglobulin superfamily) may lead to decreased proliferation of aging MuSC subpopulations. By blocking CD47 selective polyadenylation mediated by morph or blocking Thrombospondin-1 (THBS1) /CD47 signaling pathway by antibodies, the defects of MuSC regeneration in elderly mice can be overcome, thus improving muscle regeneration in elderly mice [51], which has therapeutic significance. The results of this study provide a new therapeutic target for improving muscle repair ability during aging.

Secondly, aging T cells will secrete inflammatory factors such as senescence associated secretory phenotype (SASP) to accelerate the formation of human inflammatory microenvironment. In the inflammatory microenvironment, excessive cytokines promote the deterioration of skeletal muscle fiber diameter and protein content.It also promotes skeletal muscle metabolic breakdown [52], leading to muscle proteolysis and muscle cell apoptosis [53], and eventually sarcopenia.In addition, T cells also play a role in regulating repair and regeneration after muscle injury. Aging T cells may weaken this regulatory effect, leading to a decline in muscle regeneration.In particular, aging T cells may affect the activity of satellite cells (muscle stem cells), which are essential for muscle regeneration.

On the other hand, animal experiments have found that mice transplanted with probiotics or healthy intestinal microbes have increased skeletal muscle mass, decreased muscle atrophy markers, and enhanced muscle oxidative metabolism, suggesting that intestinal flora plays an important role in skeletal muscle metabolism [54]. Intestinal flora can affect muscle mass by changing amino acid bioavailability, participating in lipid metabolism regulation, and affecting bile acid metabolism [55]. Therefore, T cells can indirectly affect skeletal muscle metabolism by regulating intestinal flora.

In conclusion, aging T cells affect skeletal muscle metabolism through multiple mechanisms such as chronic inflammation, muscle regeneration, muscle remodeling, muscle atrophy, and intestinal flora, leading to impaired muscle function and a decline in muscle mass and strength. So maintaining a healthy immune system and slowing down T-cell aging may help maintain muscle health and function.

Conclusion and prospect

A healthy immune system seems to be the secret to centenarians’ longevity, which is also contributing to our growing understanding of immune aging.To study the interrelationship between T cell aging and human tissue structure, and to understand the underlying mechanism is an important basis for clinical intervention, hoping to find the key to improve the healthy life span of the elderly.In conclusion, the imbalance of T cell metabolism is the regulator that drives aging-related diseases, so T cell targeted therapy, including clearing senescent T cells and maintaining T cell function, may open up a new therapeutic direction for aging-related diseases.

Data availability

No datasets were generated or analysed during the current study.

References

  1. Barbé-Tuana F, Funchal G, Schmitz C, et al. The interplay between immunosenescence and age-related diseases[J]. Semin Immunopathol. 2020;42(5):545–57.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Roca F, Lang PO, Chassagne P. Chronic neurological disorders and related comorbidities: role of age-associated physiological changes[J]. Handb Clin Neurol. 2019;167:105–22.

    Article  PubMed  Google Scholar 

  3. Aspinall R, Lang PO. Vaccine responsiveness in the elderly: best practice for the clinic[J]. Expert Rev Vaccines. 2014;13(7):885–94.

    Article  CAS  PubMed  Google Scholar 

  4. Liu Y, Sanoff HK, Cho H, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging[J]. Aging Cell. 2009;8(4):439–48.

    Article  CAS  PubMed  Google Scholar 

  5. Elyahu Y, Hekselman I, Eizenberg-Magar I, et al. Aging promotes reorganization of the CD4 T cell landscape toward extreme regulatory and effector phenotypes[J]. Sci Adv. 2019;5(8):eaaw8330.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Callender LA, Carroll EC, Bober EA, et al. Divergent mechanisms of metabolic dysfunction drive fibroblast and T-cell senescence[J]. Ageing Res Rev. 2018;47:24–30.

    Article  CAS  PubMed  Google Scholar 

  7. Spyridopoulos I, Martin-Ruiz C, Hilkens C, et al. CMV seropositivity and T-cell senescence predict increased cardiovascular mortality in octogenarians: results from the Newcastle 85 + study[J]. Aging Cell. 2016;15(2):389–92.

    Article  CAS  PubMed  Google Scholar 

  8. Wan RH, Lu J. Influencing factors of macrovascular complications in type 2 diabetes mellitus [J]. J Second MIL Med Univ. 2019;41(01):75–80.

    Google Scholar 

  9. Zheng Mengyi ZHAO, Quanhui L, Yingchi, et al. Detection rate and influencing factors of early vascular senescence in Kailuan study aged ≤ 50 years [J]. Chin J Hypertens. 2019;28(04):355–61.

    Google Scholar 

  10. Chen J, Zhang X, Millican R, et al. Recent progress in in vitro models for atherosclerosis Studies[J]. Front Cardiovasc Med. 2021;8:790529.

    Article  CAS  PubMed  Google Scholar 

  11. Guzik TJ, Touyz RM. Oxidative stress, inflammation, and vascular aging in Hypertension[J]. Hypertension. 2017;70(4):660–7.

    Article  CAS  PubMed  Google Scholar 

  12. Trott DW, Machin DR, Phuong T, et al. T cells mediate cell non-autonomous arterial ageing in mice[J]. J Physiol. 2021;599(16):3973–91.

    Article  CAS  PubMed  Google Scholar 

  13. Childs BG, Li H, van Deursen JM. Senescent cells: a therapeutic target for cardiovascular disease[J]. J Clin Invest. 2018;128(4):1217–28.

    Article  PubMed  PubMed Central  Google Scholar 

  14. González-Gualda E, Baker AG, Fruk L, et al. A guide to assessing cellular senescence in vitro and in vivo[J]. FEBS J. 2021;288(1):56–80.

    Article  PubMed  Google Scholar 

  15. Ungvari Z, Tarantini S, Donato AJ, et al. Mech Vascular Aging[J] Circ Res. 2018;123(7):849–67.

    CAS  Google Scholar 

  16. Nicoletti C. Age-associated changes of the intestinal epithelial barrier: local and systemic implications[J]. Expert Rev Gastroenterol Hepatol. 2015;9(12):1467–9.

    Article  CAS  PubMed  Google Scholar 

  17. Terzuoli E, Meini S, Cucchi P, et al. Antagonism of bradykinin B2 receptor prevents inflammatory responses in human endothelial cells by quenching the NF-kB pathway activation[J]. PLoS ONE. 2014;9(1):e84358.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Hasegawa Y, Saito T, Ogihara T, et al. Blockade of the nuclear factor-κB pathway in the endothelium prevents insulin resistance and prolongs life spans[J]. Circulation. 2012;125(9):1122–33.

    Article  CAS  PubMed  Google Scholar 

  19. Kida Y, Goligorsky MS, Sirtuins. Cell senescence, and vascular Aging[J]. Can J Cardiol. 2016;32(5):634–41.

    Article  PubMed  Google Scholar 

  20. Xu C, Wang L, Fozouni P, et al. SIRT1 is downregulated by autophagy in senescence and ageing[J]. Nat Cell Biol. 2020;22(10):1170–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Covarrubias AJ, Perrone R, Grozio A, et al. NAD(+) metabolism and its roles in cellular processes during ageing[J]. Nat Rev Mol Cell Biol. 2021;22(2):119–41.

    Article  CAS  PubMed  Google Scholar 

  22. Weng NP, Akbar AN, Goronzy J. CD28(-) T cells: their role in the age-associated decline of immune function[J]. Trends Immunol. 2009;30(7):306–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Carrasco E, Gómez D L H M, Gabandé-Rodríguez E, et al. The role of T cells in age-related diseases[J]. Nat Rev Immunol. 2022;22(2):97–111.

    Article  CAS  PubMed  Google Scholar 

  24. Rodriguez IJ, Lalinde RN, Llano LM, et al. Immunosenescence Study of T Cells: a systematic Review[J]. Front Immunol. 2020;11:604591.

    Article  CAS  PubMed  Google Scholar 

  25. Consortium AB, Zhang L, Guo J et al. A framework of biomarkers for vascular aging: a consensus statement by the Aging Biomarker Consortium[J]. Life MedicineLife Medicine, 2023,2(4).

  26. Annaert P, Brouwers J, Bijnens A, et al. Ex vivo permeability experiments in excised rat intestinal tissue and in vitro solubility measurements in aspirated human intestinal fluids support age-dependent oral drug absorption[J]. Eur J Pharm Sci. 2010;39(1–3):15–22.

    Article  CAS  PubMed  Google Scholar 

  27. Jie Q, Helan T. Changes of intestinal mucosal barrier injury and sIgA levels in rats exposed to positive acceleration [J]. Chin J PLA Med. 2016;41(10):865–8.

    Google Scholar 

  28. Shi B, Feng ZQ, Li WB, et al. Low G preconditioning reduces liver injury induced by high + Gz exposure in rats[J]. World J Gastroenterol. 2015;21(21):6543–9.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Shunjin F. Liu Chaoping.Relationship between intestinal mucosal barrier function and TLR9 and T cell subsets in patients with acute severe pancreatitis [J]. Int J Chin Digestion. 2019;28(19):992–8.

    Google Scholar 

  30. Sharp LL, Jameson JM, Cauvi G, et al. Dendritic epidermal T cells regulate skin homeostasis through local production of insulin-like growth factor 1[J]. Nat Immunol. 2005;6(1):73–9.

    Article  CAS  PubMed  Google Scholar 

  31. Boismenu R, Havran WL. Modulation of epithelial cell growth by intraepithelial gamma delta T cells[J]. Science. 1994;266(5188):1253–5.

    Article  CAS  PubMed  Google Scholar 

  32. Cheroutre H, Lambolez F, Mucida D. The light and dark sides of intestinal intraepithelial lymphocytes[J]. Nat Rev Immunol. 2011;11(7):445–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Santiago AF, Alves AC, Oliveira RP, et al. Aging correlates with reduction in regulatory-type cytokines and T cells in the gut mucosa[J]. Immunobiology. 2011;216(10):1085–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Haibo S. Wang Jiang.Advances in molecular mechanisms of intestinal mucosal barrier dysfunction induced by systemic inflammatory response syndrome [J]. Chin J Emerg Resusc Disaster Med, 21,16(1):101–104108.

  35. Song Hongli L, Sa M, Li. etc.TNF-α influences the expression of tight junction protein in intestinal mucosal epithelial cells [J]. World J Chin Digestion. 2004;12(6):1303–6.

    Article  Google Scholar 

  36. DeJong EN, Surette MG, Bowdish D. The gut microbiota and unhealthy aging: disentangling cause from Consequence[J]. Cell Host Microbe. 2020;28(2):180–9.

    Article  CAS  PubMed  Google Scholar 

  37. Bunker JJ, Bendelac A. IgA Responses Microbiota[J] Immun. 2018;49(2):211–24.

    CAS  Google Scholar 

  38. Hirota K, Turner JE, Villa M, et al. Plasticity of Th17 cells in Peyer’s patches is responsible for the induction of T cell-dependent IgA responses[J]. Nat Immunol. 2013;14(4):372–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Linterman MA, Pierson W, Lee SK, et al. Foxp3 + follicular regulatory T cells control the germinal center response[J]. Nat Med. 2011;17(8):975–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Neumann C, Blume J, Roy U, et al. c-Maf-dependent T(reg) cell control of intestinal T(H)17 cells and IgA establishes host-microbiota homeostasis[J]. Nat Immunol. 2019;20(4):471–81.

    Article  CAS  PubMed  Google Scholar 

  41. Stebegg M, Silva-Cayetano A, Innocentin S, et al. Heterochronic faecal transplantation boosts gut germinal centres in aged mice[J]. Nat Commun. 2019;10(1):2443.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Sage PT, Tan CL, Freeman GJ, et al. Defective TFH cell function and increased TFR cells contribute to defective antibody production in Aging[J]. Cell Rep. 2015;12(2):163–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Sato S, Kiyono H, Fujihashi K. Mucosal immunosenescence in the gastrointestinal tract: a Mini-Review[J]. Gerontology. 2015;61(4):336–42.

    Article  CAS  PubMed  Google Scholar 

  44. Xu Xiaorong G, Jian W, Jing, et al. Research progress of the relationship between intestinal flora and psoriasis [J]. J Practical Med. 2019;36(09):1153–6.

    Google Scholar 

  45. Thevaranjan N, Puchta A, Schulz C, et al. Age-Associated Microbial Dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage Dysfunction[J]. Cell Host Microbe. 2017;21(4):455–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Clark RI, Salazar A, Yamada R, et al. Distinct shifts in Microbiota Composition during Drosophila Aging impair intestinal function and drive Mortality[J]. Cell Rep. 2015;12(10):1656–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Biton M, Haber AL, Rogel N, et al. T Helper Cell cytokines modulate intestinal stem cell Renewal and Differentiation[J]. Cell. 2018;175(5):1307–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Saini J, McPhee JS, Al-Dabbagh S, et al. Regenerative function of immune system: modulation of muscle stem cells[J]. Ageing Res Rev. 2016;27:67–76.

    Article  CAS  PubMed  Google Scholar 

  49. Xiang Y, Dai J, Xu L, et al. Research progress in immune microenvironment regulation of muscle atrophy induced by peripheral nerve injury[J]. Life Sci. 2021;287:120117.

    Article  CAS  PubMed  Google Scholar 

  50. Wang Y, Wehling-Henricks M, Welc SS, et al. Aging of the immune system causes reductions in muscle stem cell populations, promotes their shift to a fibrogenic phenotype, and modulates sarcopenia[J]. FASEB J. 2019;33(1):1415–27.

    Article  CAS  PubMed  Google Scholar 

  51. Porpiglia E, Mai T, Kraft P, et al. Elevated CD47 is a hallmark of dysfunctional aged muscle stem cells that can be targeted to augment regeneration[J]. Cell Stem Cell. 2022;29(12):1653–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Calvani R, Marini F, Cesari M, et al. Systemic inflammation, body composition, and physical performance in old community-dwellers[J]. J Cachexia Sarcopenia Muscle. 2017;8(1):69–77.

    Article  PubMed  Google Scholar 

  53. Zhang X, Li H, He M, et al. Immune system and sarcopenia: presented relationship and future perspective[J]. Exp Gerontol. 2022;164:111823.

    Article  CAS  PubMed  Google Scholar 

  54. Zhou Min WANG, Kaige Z, Lian, et al. Research progress of microbial-gut-muscle axis regulating skeletal muscle metabolism and function [J]. Chin J Veterinary Sci. 2019;53(9):2845–57.

    Google Scholar 

  55. Zhou Zhangning ZHANG, Qin GUI, Qifeng et al. Research progress of intestinal microecology and sarcosis [J]. Chin J Geriatr, 202,41(5):610–3.

Download references

Acknowledgements

Not applicable.

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Medical College, School of Medicine, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China

    Ling-ling Xu & Xiang Chen

  2. Department of Gerontology, CR & WISCO General Hospital, Wuhan University of Science and Technology, Wuhan, Hubei, 430080, China

    Jing-ping Cheng

Authors
  1. Ling-ling Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jing-ping Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

xll and cx-Wrote the main manuscript textcjp put forward ideasAll authors reviewed the manuscript.

Corresponding author

Correspondence to Jing-ping Cheng.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, Ll., Chen, X. & Cheng, Jp. The effect of T cell aging on the change of human tissue structure. Immun Ageing 21, 26 (2024). https://doi.org/10.1186/s12979-024-00433-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12979-024-00433-4

Keywords

Immunity & Ageing

ISSN: 1742-4933

Contact us